Northern Financial Advisors Inc Has $581,000 Stock Holdings in Colgate-Palmolive (NYSE:CL)

Northern Financial Advisors Inc trimmed its stake in shares of Colgate-Palmolive (NYSE:CL) by 4.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 7,284 shares of the company’s stock after selling 361 shares during the quarter. Northern Financial Advisors Inc’s holdings in Colgate-Palmolive were worth $581,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently added to or reduced their stakes in the stock. OFI Invest Asset Management bought a new position in shares of Colgate-Palmolive in the third quarter valued at approximately $25,000. Avion Wealth raised its stake in shares of Colgate-Palmolive by 78.1% in the fourth quarter. Avion Wealth now owns 399 shares of the company’s stock valued at $32,000 after acquiring an additional 175 shares during the last quarter. McGlone Suttner Wealth Management Inc. bought a new position in shares of Colgate-Palmolive in the fourth quarter valued at approximately $34,000. Kayne Anderson Rudnick Investment Management LLC raised its position in Colgate-Palmolive by 142.0% in the 3rd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 496 shares of the company’s stock worth $35,000 after purchasing an additional 291 shares during the last quarter. Finally, West Branch Capital LLC raised its position in Colgate-Palmolive by 24.0% in the 4th quarter. West Branch Capital LLC now owns 682 shares of the company’s stock worth $54,000 after purchasing an additional 132 shares during the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research analysts recently weighed in on the stock. StockNews.com cut shares of Colgate-Palmolive from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, February 20th. The Goldman Sachs Group began coverage on shares of Colgate-Palmolive in a report on Friday, March 1st. They set a “buy” rating and a $93.00 target price for the company. Wells Fargo & Company lifted their target price on shares of Colgate-Palmolive from $90.00 to $92.00 and gave the stock an “equal weight” rating in a report on Monday, April 29th. Citigroup lifted their target price on shares of Colgate-Palmolive from $95.00 to $100.00 and gave the stock a “buy” rating in a report on Tuesday, April 16th. Finally, UBS Group boosted their price target on shares of Colgate-Palmolive from $93.00 to $95.00 and gave the company a “buy” rating in a report on Monday, January 29th. Three equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat.com, Colgate-Palmolive currently has a consensus rating of “Moderate Buy” and a consensus target price of $91.44.

Insiders Place Their Bets

In other Colgate-Palmolive news, CEO Noel R. Wallace sold 50,000 shares of the stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $83.15, for a total transaction of $4,157,500.00. Following the transaction, the chief executive officer now owns 274,179 shares in the company, valued at approximately $22,797,983.85. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other Colgate-Palmolive news, CEO Noel R. Wallace sold 50,000 shares of the stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $83.15, for a total transaction of $4,157,500.00. Following the transaction, the chief executive officer now owns 274,179 shares in the company, valued at approximately $22,797,983.85. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Noel R. Wallace sold 69,948 shares of the stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $84.22, for a total transaction of $5,891,020.56. Following the sale, the chief executive officer now owns 286,881 shares in the company, valued at approximately $24,161,117.82. The disclosure for this sale can be found here. Insiders have sold a total of 159,048 shares of company stock worth $13,336,846 in the last quarter. Corporate insiders own 0.34% of the company’s stock.

Colgate-Palmolive Stock Performance

Shares of CL stock traded down $0.46 on Wednesday, reaching $93.62. The stock had a trading volume of 3,284,846 shares, compared to its average volume of 4,649,866. The company has a quick ratio of 0.70, a current ratio of 1.06 and a debt-to-equity ratio of 13.21. The firm’s 50-day moving average is $88.64 and its two-hundred day moving average is $82.63. The firm has a market capitalization of $76.81 billion, a price-to-earnings ratio of 29.77, a P/E/G ratio of 3.43 and a beta of 0.40. Colgate-Palmolive has a 12 month low of $67.62 and a 12 month high of $94.40.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, April 26th. The company reported $0.86 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.82 by $0.04. The company had revenue of $5.07 billion for the quarter, compared to analysts’ expectations of $4.96 billion. Colgate-Palmolive had a net margin of 13.22% and a return on equity of 485.40%. Colgate-Palmolive’s quarterly revenue was up 6.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.73 EPS. On average, research analysts expect that Colgate-Palmolive will post 3.52 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Monday, April 22nd will be issued a $0.50 dividend. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.48. This represents a $2.00 annualized dividend and a yield of 2.14%. The ex-dividend date of this dividend is Friday, April 19th. Colgate-Palmolive’s dividend payout ratio is currently 63.29%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.